RECURSION PHARMACEUTICALS IN

Ticker: RXRX CUSIP: 75629V104 Class: Common Stock

BRAVE ASSET MANAGEMENT INC's Holding History (CIK: 0001085867)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025
Shares 11,433 Value ($000) $47 Avg Close $4.95 Range $3.81 - $7.18
Q3 2025
Shares 11,433 Value ($000) $56 Avg Close $5.25 Range $4.45 - $7.15
Q2 2025
Shares 11,433 Value ($000) $58 Avg Close $4.91 Range $3.79 - $6.11
Q1 2025
Shares 11,433 Value ($000) $60 Avg Close $7.29 Range $5.19 - $12.36
Q4 2024
Shares 11,433 Value ($000) $77 Avg Close $6.72 Range $5.60 - $9.55
Q3 2024
Shares 10,000 Value ($000) $66 Avg Close $7.17 Range $5.88 - $8.73
Q2 2024
Shares 10,000 Value ($000) $75 Avg Close $8.72 Range $6.75 - $10.66
Q1 2024
Shares 10,000 Value ($000) $100 Avg Close $11.14 Range $8.68 - $15.74
Q4 2023
Shares 15,000 Value ($000) $148 Avg Close $7.13 Range $4.97 - $11.17